Differentiation-related changes in the cell cycle traverse

International Review of Cytology

Volumn 189, Issue , 1999, Pages 1-58

  Studzinski, George P ^a   Harrison, Lawrence E ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cell cycle; Cell differentiation; Cyclin dependent kinases; E2F; p21 Cip1; p27 Kip1; Polyploidization; pRb

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; RETINOBLASTOMA PROTEIN;

CELL CYCLE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL TYPE; MEGAKARYOCYTE; POLYPLOIDY; PRIORITY JOURNAL; REVIEW;

EID: 0032917188     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7696(08)61384-4     Document Type: Review

References (333)

1. Adachi, M., Roussel, M. F., Havenith, K., and Sherr, C. J. (1997). Features of macrophage differentiation induced by p19INK4d, a specific inhibitor of cyclin D-dependent kinases. Blood 90, 126-137.
2. Afshari, C. A., Nichols, M. A., Xiong, Y., and Mudryj, M. (1996). A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Differ. 7, 979-988.
3. Antonov, A. S., Munn, D. H., Kolodgie, F. D., Virmani, R., and Gerrity, R. G. (1997). Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistric with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kipl) regulatory checkpoint. J. Clin. Invest. 99, 2867-2876.
4. Arany, I., Brysk, M. M., Calhoun, K. H., and Tyring, S. K. (1996). Differentiation and IFN gamma regulate WAF1/CIP1 transcription in p53-independent and p53-dependent pathways in epithelial cells. In Vivo 10,119-123.
5. Asiedu, C., Biggs, J., Briggs, J., and Kraft, A. S. (1997). Complex regulation of CDK2 during phorbol ester-induced hematopoietic differentiation. Blood 90, 3430-3437.
6. Barboule, N., Chadebech, P., Baldin, V., Vidai, S., and Valette, A. (1997). Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line. Oncogene 15, 2867-2875.
7. Barnard, J., and Warwick, G. (1994). Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ. 4, 495-501.
8. Baron, R., Racesloot, J. H., Neff, L., Chakraborty, M., Chatterjee, D., Lomri, A., and Home, W. C. (1993). In "Cellular & Molecular Biology of Bone." Academic Press, San Diego.
9. Bar-Shavit, Z., Kahn, A. J., Stone, K. R., Trial, J., Milliard, T., Reitsma, P. H., and Teitelbaum, S. L. (1986). Reversibility of vitamin D-induced human leukemia cell-line maturation. Endocrinology 118, 679-686
10. Bartek, J., Bartkova, J., and Lukas, J. (1997). The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res. 237,1-6.
11. Bartkova, J., Zemanova, M., and Bartek, J. (1996). Expression of CDK7/CAK in normal and tumor cells of diverse histogenesis, cell-cycle position and differentiation. Int. J. Cancer 66, 732-737.
12. Bassnett, S., and Malaie, D. (1997). Chromatin degradation in differentiating fiber cells of the eye lens. J. Cell Biol. 137, 37-49.
13. Beere, H., and Hickman, J. (1993). Differentiation: A suitable strategy for cancer chemotherapy? Anti-Cancer Drug Design 8, 299-322.
14. Beijersbergen, R. L., Kerkhoven, R. M., Zhu, L., Carlee, L., Voorhoeve, P. M., and Bernards, R. (1994). E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8, 2680-2690.
15. Bennett, A. M., and Tonks, N. K. (1997). Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278, 1288-1291.
16. Bernstein, S., Sherman, M., Hass, R., Nakamura, T., Kharbanda, S., and Kufe, D. (1991). Effects of hexamethylene biscetamide on induction of monocytic differentiation of human U-937 myeloid leukemia cells. Biochem. PharmacoL 42, 403-407.
17. Bertolotto, C, Bille, K., Ortonne, J., and Ballotti, R. (1998). In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter. Oncogene 16,1665-1670.
18. Binderup, L., Binderup, E., and Godtredsen, W. O. (1997). Development of new vitamin D analogs. //; "Vitamin D" (D. Feldman, Glorieux F. H., and Pike J. W., eds.), pp. 1027-1044. Academic Press, San Diego.
19. Blagosklonny, M. V., Prabhu, N. S., and El-Deiry, W. S. (1997). Defects in p21WAFl/CIPl, Rb, and c-myc signaling in phorbol ester-resistant cancer cells. Cancer Res. 57, 320-325.
20. Blair, O. C, Carbone, R., and Sartorelli, A. C. (1985). Differentiation of HL60 promyelocytic leukemia cells monitored by flow cytometric measurement of nitro blue tetrazolium (NET) reduction. Cytometry 6, 54-61.
21. Boettger-Tong, H., Shipley, G., Hsu, C., and Stancel, G. (1997). Cultured human uterine smooth muscle cells are retinoid responsive. Proc. Soc. Exp. Biol. Med. 215, 59-65.
22. Boffa, L., Lupton, J., Mariani, M., Ceppi, M., Newmark, H., Scalmati, A., and Lipkin, M. (1992). Modulation of colonie epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res. 52, 5906-5912.
23. Bogenmann, E., Torres, M., and Matsushima H. (1995). Constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation. Oncogene 10, 1915-1925.
24. Bortell, R., Owen, T. A., Bidwell, J. P., Gavazzo, P., Breen, E., van Wijnen, A. J., DeLuca, H. F., Stein, J. L., Lian, J. B., and Stein, G. S. (1992). Vitamin D-responsive protein-DNA interactions at multiple promoter regulatory elements that contribute to the level of rat osteocalcin gene expression. Proc. Natl. Acad. Sei. USA 89, 6119-6123.
25. Bramlage, B., Kosciessa, U., and Doenecke, D. (1997). Differential expression of the murine histone genes H3.3A and H3.3B. Differentiation 62, 13-20.
26. Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., and Kouzarides, T. (1998). Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-600.
27. Breitman, T., and He, R. (1990). Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60. Cancer Res. 50, 6268-6273.
28. Brelvi, Z. S., and Studzinski, G. P. (1986). Changes in the expression of oncogenes encoding nuclear phosphoproteins but not c-Ha-ras have a relationship to monocytic differentiation of HL60 cells. J. Cell Biol. 102, 2234-2243.
29. Burger, C, Wick, M., and Muller, R. (1994). Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells. J. Cell Sei. 107, 2047-2054.
30. Camps, M., Chabert, C, Muda, M., Boschert, U., Gillieron, C., and Arkinstall, S. (1998). Induction of the mitogen-activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12. FEBS Lett. 425, 271-276.
31. Cardoso, M. C., Leonhardt, H., and Nadal-Ginard, B. (1993). Reversal of terminal differentiation and control of DNA replication: Cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74, 979-992.
32. Cargnello, R., Celio, M., Schwaller, B., and Gotzos, V. (1996). Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentiation. Biochim. Biophys. Acta 1313, 201-208.
33. Casaccia-Bonnefil, P., Tikoo, R., Kiyokawa, H., Friedrich, V., Jr., Chao, M. V., and Koff, A. (1997). Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27/Kipl. Genes Dev. 11, 2335-2346.
34. Chandrasekaran, C., Coopersmith, C. M., and Gordon, J. I. (1996). Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators. J. Biol. Chem. 271, 28414-28421.
35. Chen, P., Scully, P., Shew, J., Wang, J., and Lee, W. (1989). Phosphorylation of the retinoblastoma gene product is modulated during cell cycle and cellular differentiation. Cell 58,1193-1198.
36. Chen, P. L., Riley, D. J., Chen, Y., and Lee, W. H. (1996). Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10, 2794-2804.
37. Chin, L., Schreiber-Agus, N., Pellicer, I., Chen, K., Lee, H. W., Dudast, M., Cordon-Cardo, C., and DePinho, R. A. (1995). Contrasting roles for myc and Mad proteins in cellular growth and differentiation. Proc. Natl. Acad. Sei. USA 92, 8488-8492.
38. Coolican, S. A., Samuel, D. S., Ewton, D. Z., McWade, F. J., and Florini, J. R. (1997). The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272, 6653-6662.
39. Craig, C., Wersto, R., Kim, M., Ohri, E., Li, Z., Katayose, D., Lee, S. J., Trepel, J., Cowan, K., and Seth, P. (1997). A recombinant adenovirus expressing p27Kipl induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 14,2283-2289.
40. Cross, H., Pavleka, M., Slavik, J., and Peterlik, M. (1992). Growth control of human cancer cells by vitamin D and calcium in vitro. J. Natl. Cancer Inst. 84, 1355-1357.
41. Crowe, D. L. (1998). Retinoic acid receptor beta induces terminal differentiation of squamous cell carcinoma lines in the absence of cyclin-dependent kinase inhibitor expression. Cancer Res. 58,142-148.
42. Cultraro, C. M., Bino, T., and Segal, S. (1997). Function of the c-myc antagonist Mad 1 during a molecular switch from proliferation to differentiation. Mol. Cell Biol. 17, 2353-2359.
43. Dalton, S. (1992). Cell cycle regulation of the human cdc2 gene. EMBO J. 11,1797-1804.
44. Danish, R., El-awar, O., Weber, B., Langmore, J., Turka, L., Ryan, J., and Clarke, M. (1992). c myb effects on kinetic events during MEL cell differentiation. Oncogene 7, 901-907.
45. Darzynkiewicz, Z., Traganos, F., Xue, S., and Melamed, M. (1981). Effect of n-butyrate on cell cycle progression and in situ chromatin structure of L1210 cells. Exp. Cell Res. 136, 279-293.
46. Datta, B., Min, W., Burma, S., and Lengyel, P. (1998). Increase in p202 expression during skeletal muscle differentiation: Inhibition of MyoD protein expression and activity by p202. Mol. Cell. Biol. 18,1074-1083.
47. Datta, N. S., Williams, J., Caldwell, J., Curry, A. M., Ashcraft, E. K., and Long, M. W. (1996). Novel alterations in CDKl/cyclin Bl kinase complex formation occur during the acquisition of a polyploid DNA content. Mol. Biol. Cell 7, 209-223.
48. David, J. P., Neff, L., Rincon, M., and Baron, R. (1997). Osteoclast differentiation: Evidence for an indirect mechanism of action of la,25(OH)2D3. In "Proceedings of the Tenth Workshop on Vitamin D-Strasburg, France" (A. W. Norman, R. Bullion, and M. Thomasset, eds.), pp. 673-674. Univ. of California Press, Riverside.
49. Dean, M., Levine, R. A., and Campisi, J. (1986). c-myc regulation during retinoic acid-induced differentiation of F9 cells is posttranscriptional and associated with growth arrest. Mol. Cell. Biol. 6, 518-524.
50. Delvin, P. P., Lopez, V., Levy, E., and Menard, D. (1996). Calcitriol differentially modulates mRNA encoding calcitriol receptors and calcium-binding protein 9 kDa in human fetal jejunum. Biochem. Biophys. Res. Commun. 224, 544-548.
51. Demay, M. B., Kiernam, M. S., DeLuca, H. F., and Kronenberg, H. M. (1992). Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sei. USA 89, 8097-8101.
52. de Mora, J. F., Uren, A., Heidaran, M., and Santos, E. (1997). Biological activity of p27kipl and its amino- and carboxy-terminal domains in G2/M transition of Xenopus oocytes. Oncogens 15, 2541-2551.
53. Deng, C, Zhang, P., Harper, J. W., Elledge, S. L., and Leder, P. (1995). Mice lacking p21CIPl/ WAF1 undergo normal development, but are defective in Gl checkpoint control. Cell 82, 675-684.
54. Denko, N., Langland, R., Barton, M., and Lieberman, M. A. (1997). Uncoupling of S-phase and mitosis by recombinant cytotoxic necrotizing factor 2 (CNF2). Exp. Cell Res. 234,132-138.
55. DePinho, R. A. (1998). The cancer-chromatin connection. Nature 391, 533-536.
56. Di Cunto, F., Topley, G., Calautti, E., Hsiao, J., Ong, L., Seth, P. K., and Dotto, G. P. (1998). Inhibitory function of p21Cipl/Wafl in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 280,1069-1072.
57. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sei. USA 20, 9363-9367.
58. Dimri, G. P., Testori, A., Acosta, M., and Campisi, J. (1996). Replicative senescence, aging and growth-regulatory transcription factors. Biol. Signals 5, 154-162.
59. Djelloul, S., Forgue-Lafitte, M., Hermelin, B., Mareel, M., Bruyneel, E., Baldi, A., Giordano, A., Chastre, E., and Gespach, C. (1997). Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonie Caco-2 cells. FEBS Lett. 406, 234-242.
60. Dmitrovsky, E., Moy, D., Miller, W. H., Jr., Li, A., and Masui, H. (1990). Retinoic acid causes a decline inTGF-alpha expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line. Oncogene Res. 5, 233-239.
61. Dobashi, Y., Kudoh, T., Toyoshima, K., and Akiyama, T. (1996). Persistent activation of CDK4 during neuronal differentiation of rat phenochromocytoma PC12 cells. Biochem. Biophys. Res. Commun. 221, 351-355.
62. Dong, X., Zavitz, K. H., Thomas, B. J., Lin, M., Campbell, S., and Zipursky, S. L. (1997). Control of Gl in the developing drosophila eye: RCA 1 regulates cyclin A. Genes Dev. 11, 94-105.
63. Dou, Q. P., Levin, A. H., Zhao, S., and Pardee, A. B. (1993). Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res. 53, 1493-1497.
64. Dubart, A., Romeo, P. H., Vainchenker, W., and Dumenil, D. (1996). Constitutive expression of GATA-2 interferes with the cell-cycle regulation. Blood 87, 3711-3721.
65. Duchrow, M., Schluter, C., Key, G., Kubbutat, M. H., Wohlenberg, C., Flad, H. D., and Gerdes, J. (1995). Cell proliferation-associated nuclear antigen defined by antibody Ki-67: A new kind of cell cycle-maintaining proteins. Arch. Immunol. Ther. Exp. (Warsz) 43, 117-121.
66. Dulic, V., Stein, G. H., Far, D. F., and Reed, S. I. (1998). Nuclear accumulation of p21Cipl at the onset of mitosis: A role at the G2/M-phase transition. Mot. Cell. Biol. 18, 546-557.
67. Durand, B., Gao, F. B., and Raff, M. (1997). Accumulation of the cyclin-dependent kinase inhibitor p27/Kipl and the timing of oligodendrocyte differentiation. EMBOJ. 16,306-317.
68. Ebeling, J., Vandenbark, G., Kuhn, L., Ganong, B., Bell, R., and Niedel, J. (1985). Diacylglycerols mimic phorbol diester induction of leukemic cell differentiation. Proc. Natl. Acad. Sei. USA 82, 815-819.
69. el-Deiry, W., Tokino, T., Velculescu, V., Levy, D., Parsons, R., Trent, J., Lin, D., Mercer, W., Kinzler, K., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
70. el-Deiry, W. S., Tokino, T., Waldman, T., Oliner, J. D., Velculescur, V. E., Burrell, M., Hill, D. E., Healy, E., Rees, J. L., Hamilton, S. R., et al. (1995). Topological control of p21WAFl/ CIP1 expression in normal and neoplastic tissues. Cancer Res. 55, 2910-2919.
71. Elledge, S. (1996). Cell cycle checkpoints: Preventing an identity crisis. Science 274,1664-1672.
72. Elledge, S. (1998). Mitotic arrest: Mad 2 prevents sleepy from waking up the APC. Science 279, 999-1000.
73. Elstner, E., Linker-Israeli, M., Said, J., Umiel, T., de Vos, S., Shintaku, P., Heber, D., Binderup, L., Uskokovic, M., and Koeffler, H. (1995). 20-epi-vitamin D3 analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cells. Cancer Res. 55, 2822-2830.
74. Erhardt, J. A., and Pittman, R. N. (1998). p21WAFl induces permanent growth arrest and enhances differentiation, but does not alter apoptosis in PC12 cells. Oncogene 16,443-451.
75. Farach-Carson, M. C, and Ridall, A. L. (1998). Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: Cross talk between genomic and membrane-initiated pathways. Am. J. Kidney Dis. 31, 729-742.
76. Fattaey, A., Helin, K., and Harlow, E. (1993). Transcriptional inhibition by the retinoblastoma protein. Philos. Trans. R. Soc. London B Biol. Sei. 340, 333-336.
77. Feldman, D., Glorieux, F. H., and Pike, J. W. (1997). "Vitamin D." Academic Press, San Diego.
78. Fibach, E., Treves, A., and Rachmilewitz, E. A. (1983). Spontaneous commitment of murine erythroleukemic cells to terminal differentiation. Cancer Res. 43, 4136-4141.
79. Flink, I. L., Oana, S., Maitra, N., Bahl, J. J., and Morkin, E. (1998). Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. /. Mol. Cell. Cardiol. 30, 563-578.
80. Foley, K. P., McArthur, G. A., Queva, C., Hurlin, P. J., Soriano, P., and Eisenman, R. N. (1998). Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J. 17, 777-785.
81. 3 specific regulation of growth, morphology and fibronectin in a human osteosarcoma cell line. J. Cell. Physiol. 123, 401-409.
82. Franklin, D. S., and Xiong, Y. (1996). Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol. Biol. Cell 7, 1587-1599.
83. Freemerman, A. J., Vrana, J. A., Tombes, R. M., Jiang, H., Chellappan, S. P., Fisher, P. B., and Grant, S. (1997). Effect of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL60). Leukemia 11, 504-513.
84. Fromm, L., and Overbeck, P. A. (1996). Regulation of cyclin and cyclin-dependent kinase gene expression during lens differentiation requires the retinoblastoma protein. Oncogene 12, 69-75.
85. Galaktionov, K., Jessus, C., and Beach, D. (1995). Rafl interaction with cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev. 9,1046-1058.
86. Galaktionov, K., Chen, X., and Beach, D. (1996). Cdc25 cell cycle phosphatase as a target of c-myc. Nature 382, 511-517.
87. Gallagher, R., Said, F., Papenhausen, P., Paietta, E., and Wiernick, P. (1989). Expression of retinoic acid receptor alpha gene in acute promyelocytic leukemia. Leukemia 3, 789-795.
88. Gandarillas, A., and Watt, F. M. (1997). C-myc promotes differentiation of human epidermal stem cells. Genes Dev. 11, 2869-2882.
89. Ganter, B., Fu, S. I., and Lipsick, J. S. (1998). D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain. EMBO J. 17, 255-268.
90. Gao, C. Y., Bassnett, S., and Zelenka, P. S. (1995). Cyclin B, p34cdc2, and Hl-kinase activity in terminally differentiating lens fiber cells. Dev. Biol. 169,185-194.
91. Gao, C. Y., Zakeri, Z., Zhu, Y., He, H., and Zelenka, P. S. (1997). Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens. Dev. Genet. 20, 267-275.
92. Cartel, A. L., Serfas, M. S., Cartel, M., Goufman, E., Yu, G. S., el-Deiry, W. S., and Tyner, A. L. (1996). p21 (WAF1/CIP1) expression is induced in newly nondividing cell in diverse epithelia and during differentiation of the CaCo2 intestinal cell line. Exp. Cell Res. 227, 171-181.
93. Gautier, J., Solomon, M., Booher, R., Bazan, F., and Kirschner, M. (1991). cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67,197-211.
94. Ge, R. S., and Hardy, M. P. (1997). Decreased cyclin A2 and increased cyclin Gl levels coincide with loss of proliferative capacity in rat Leydig cells during pubertal development. Endocrinology 138, 3719-3726.
95. Glaise, D., Ilyin, G. P., Loyer, P., Cariou, S., Nilodeau, M., Lucas, J., Puisieux, A., Oxturk, M., and Guguen-Guillouzo, C. (1998). Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines. Cell Growth Differ. 9, 165-176.
96. Glauber, J., Wandersee, N., Little, J., and Ginder, G. (1991). 5′ flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol. Cell. Biol. 11, 4690-4697.
97. Godyn, J. J., Xu, H., Zhang, F., Kolla, S., and Studzinski, G. P. (1994). A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D3. Cell Prolif. 27,37-46.
98. Gore, S., Samid, D., and Weng, L. (1997). Impact of the putative differentiating agents sodium phenylbutryrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells. Clin. Cancer Res. 3, 1755-1762.
99. Griffin, J. D., Ritz, J., Nadler, L. M., and Schlossman, S. F. (1981). Expression of myeloid differentiation antigens on normal and malignant myeloid cells. /. Clin. Invest. 68,932-941.
100. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadal-Ginard, B. (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
101. Guidato, S., MsLoughlin, D. M., Grierson, A. J., and Miller, C. C. (1998). Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity. /. Netirochem. 70, 335-340.
102. Gum, J., Kam, W., Byrd, J., Hicks, J., Sleisenger, M., and Kim, Y. (1987). Effects of sodium butyrate on human colonie adenocarcinoma cells. /. Biol. Cliem. 262, 1092-1097.
103. Guy, C. T., Zhou, V., Kaufman, S., and Robinson, M. O. (1996). E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol. Cell. Biol. 16, 685-693.
104. Haas-Kogan, D. A., Kogan, S. C, Levi, D., Dazin, P., T'Ang, A., Fung, Y. K., and Israel, M. A. (1995). Inhibition of apoptosis by the retinoblastoma gene product. EMBOJ. 14,461-472.
105. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267,1018-1021.
106. Hannon, G., and Beach, D. (1994). p15(INK4) is a potential effector of TGF-beta induced cell cycle arrest. Nature 371, 257-261.
107. Hartwell, L., and Weinert, T. (1989). Checkpoints: Controls that ensure the order of cell cycle events. Science 246, 629-634.
108. Harvat, B., Wang, A., Seth, P., and Jetten, A. (1998). Up-regulation of p27(Kipl), p21(WAFl/ Cipl) and p!6(Ink4a) is associated with, but not sufficient for, induction of squamous differentiation. J Cell Sei. Ill, 1185-1196.
109. Hashimoto, Y., and Shudo, K. (1991). Retinoids and their nuclear receptors. Cell Biol. Rev. 25, 209-230.
110. Hatakeyama, M., and Weinberg, R. A. (1995). The role of RB in cell cycle control. Prog. Cell Cycle Res. 1, 9-19.
111. Hauser, P. J., Agrawal, D., Flanagan, M., and Pledger, W. J. (1997). The role of p27kipl in the in vitro differentiation of murine keratinocytes. Cell Growth Differ. 8, 203-211.
112. Hawa, N. S., O'Riordan, J. L., and Farrow, S. M. (1996). Functional analysis of vitamin D response elements in the parathyroid hormone gene and a comparison with the osteocalcin gene. Biochem. Biophys. Res. Commun. 228, 352-357.
113. Hayflick, L., and Moorhead, P. S. (1961). The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621.
114. He, H. Y., Gao, C, Vrensen, G., and Zelenka, P. (1998). Transient activation of cyclin B/Cdc2 during terminal differentiation of lens fiber cells. Dev. Dyn. 211, 26-34.
115. Heald, R., McLoughlin, M., and McKeon, F. (1993). Human wee-1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell 74, 463-474.
116. Heerdt, B., Houston, M., and Augenlicht, L. (1994). Potentiation by short-chain fatty acids on differentiation and apoptosis in human colonie carcinoma cell lines. Cancer Res. 54,3288-3294.
117. Hewison, M., and O'Riordan, J. L. H. (1997). Immunomodulatory and cell differentiation effects of vitamin D. In "Vitamin D" (D. Feldman, F. H. Glorieux, and J. \V. Pike, eds.), pp. 447-462. Academic Press, San Diego.
118. Hirano, F., Tanaka, H., Hirano, Y., Hiramoto, M., Handa, H., Makino, I., and Scheidereit, C. (1998). Functional interference of Spl and NF kappaB through the same DNA binding site. Mol. Cell. Biol. 18, 1266-1274.
119. Hiyama, H., lavarone, A., and Reeves, S. A. (1998). Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 16, 1513-1523.
120. Hodin, R., Meng, S., Archer, S., and Tang, R. (1996). Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ. 7, 647-653.
121. Hoffmann, I., Clarke, P., Marcote, M., Karsenti, E., and Draetta, G. (1993). Phosphorylation and activation of human cdc25c by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J. 12, 53-63.
122. Hoffmann, I., Draetta, G., and Karsenti, E. (1994). Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the Gi/S transition. EMBO J. 13, 4302-4310.
123. Horiguchi-Yamada, J., Yamada, H., Nakada, S., Ochi, K., and Nemoto, T. (1994). Changes of Gl cyclins, cdk2, and cyclin A during the differentiation of HL60 cells induced by TPA. Mol. Cell. Biochem. 132, 31-37.
124. Hoyt, M. (1997). Eliminating all obstacles: Regulated proteolysis in the eukaryotic cell cycle. Cell 91, 149-151.
125. Huang, R. P., Fan, Y., Ni, Z., Mercola, D., and Adamson, E. D. (1997). Reciprocal modulation between Spl and Egr-1. Cell Biochem. 66, 489-499.
126. Hudson, K. M., Denko, N. C, Schwab, E., Oswald, E., Weiss, A., and Lieberman, M. A. (1996). Megakaryocytic cell line-specific hyperploidy by cytotoxic necrotizing factor bacterial toxins. Blood 88, 3465-3473.
127. Hulla, W., Kallay, E., Krugluger, W., Peterlik, M., and Cross, H. (1995). Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin D compounds and extracellu-lar calcium in vitro: Relation to c myc oncogene and vitamin D receptor expression. Int. J. Cancer 62, 711-716.
128. Hume, D. A., and Gordon, S. (1982). Regulation of bone-marrow macrophage proliferation. Adv. Exp. Med. Biol. 155, 261-266.
129. Hunter, T., and Pines, J. (1994). Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
130. Ishiguro, A., Spirin, K. S., Shiohara, M., Tobler, A., Norton, J. D., Rigolet, M., Shimbo, T., and Koeffier, H. P. (1995). Expression of Id2 and Id3 mRNA in human lymphocytes. Leukemia Res. 19, 989-996.
131. Ishiguro, A., Spinn, K. S., Shiohara, M., Tobler, A., Gombart, A. F., Israel, M. A., Norton, J. D., and Koeffler, H. P. (1996). Id2 expression increases with differentiation of human myeloid cells. Blood 87, 5225-5231.
132. Jahn, L., Sadoshima, J., and Izumo, S. (1994). Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells. Exp. Cell Res. 212, 297-307.
133. Jensen, T. J., Henriksen, L. O., Solvsten, H., and Kragballe, K. (1998). Inhibition of the 1,25-dihydroxyvitamin DS-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures. Biochem. Pharmacol. 55, 767-773.
134. Jiang, H., Lin, J., Su, Z. Z., Collart, F. R., Huberman, E., and Fisher, P. B. (1994). Induction of differentiation in human promyelocytic HL60 leukemia cells activates p21, WAF/CIP1, expression in the absence of p53. Oncogene 11, 3389-3396.
135. Jiang, H., Lin, J., Young, S. M., Goldstein, N. L, Waxman, S., Davila. V., Chellapan, S. P., and Fisher, P. B. (1995). Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate. Oncogene 11, 1179-1189.
136. Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H., and Okayama, H. (1994). Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13,1549-1556.
137. Jones, D. L., Alani, R. M., and Munger, K. (1997). The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cipl-mediated inhibition of cdk2. Genes Dev. 11, 2101-2111.
138. Kaffman, A., Herskowitz, I., Tjian, R., and O'Shea, E. K. (1994). Phosphorylation of the transcription factor PHO4 by a cyclin-CDK complex, PHO80-PHO85. Science 263,1153-1156.
139. Kaliman, P., Vinals, F., Testar, X., Palacin, M., and Zorzano, A. (1996). Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Cliem. 271,19146-19151.
140. Kallassy, M., Martel, N., Damour, O., Yamasaki, H., and Nakazawa, H. (1998). Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAFl gene expression. Mol. Carcinogen. 21, 26-36.
141. Karantza, V., Maroo, A., Fay, D., and Sedivy, J. M. (1993). Overproduction of Rb protein after the Gl/S boundary causes G2 arrest. Mol. Cell. Biol. 13, 6640-6652.
142. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. (1993). Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK-4. Genes Dev. 7, 331-334.
143. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972). Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
144. lyn tyrosine kinase activation in mammalian cells treated with mitomycin C. Oncogene 9,3005-3011.
145. lyn tyrosine kinase by ionizing radiation. J. Biol. Cliem. 269, 20739-20743.
146. cdc2. Cancer Res. 56, 3617-3621.
147. Kiess, M., Gill, R. M., and Hamel, P. A. (1995). Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 10, 159-166.
148. Kikuchi, J., Furukawa, Y., Iwase, S., Terui, Y., Nakamura, M., Kitagawa, S., Kitagawa, M., Komatsu, N., and Miura, Y. (1997). Polyploidization and functional maturation are two distinct processes during megakaryocytic differentiation: Involvement of cyclin-dependent kinase inhibitor p21 in polyloidization. Blood 89, 3980-3990.
149. King, R. W., Deshaies, R., Peters, J., and Kirschner, M. (1996). How proteolysis drives the cell cycle. Science 274, 1652-1659.
150. Kiyokawa, H., Ngo, L., Kurosaki, T., Rifkind, R. A., and Marks, P. A. (1992). Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells. Cell Growth Differ. 3, 377-383.
151. Knudsen, E. S., Pazzagli, C, Born, T. L., Bertolaet, B. L., Knudsen, K. E., Arden, K. C, Henry, R. R., and Feramisco, J. R. (1998). Elevated cyclins and cyclin-dependent kinase activity in the rhabdornyosarcoma cell line RD. Cancer Res. 58, 2042-2049.
152. Kobayashi, M, Yamauchi, Y., and Tanaka, A. (1998). Stable expression of antisense Rb-1 RNA inhibits terminal differentiation of mouse myoblast C2 cells. Exp. Cell Res. 239,40-49.
153. Kokunai, T., Izawa, I., and Tamaki, N. (1998). Overexpression of p21WAFl/CIPl induces cell differentiation and growth inhibition in a human glioma cell line. Int. J. Cancer 75,643-648.
154. Kolla, S. S., and Studzinski, G. P. (1994). Constitutive DNA binding of the low mobility forms of the AP-1 and SP-1 transcription factors in HL60 cells resistant to 1-beta-D-arabinofuranosylcytosine. Cancer Res. 54, 1418-1421.
155. Kruh, J. (1982). Effects of sodium butyrate, a new pharmacological agent, on cell culture. Mol. Cell. Biochem. 42, 65-82.
156. Kwon, T. K., Buchholz, M. A., Jun, D. Y., Kim, Y. H., and Nordin, A. A. (1998). The differential catalytic activity of alternatively spliced cdk2a and cdk2/3 in the Gl/S transition and early S phase. Exp. Cell Res. 238,128-135.
157. Lahti, J. M., Xiang, J., and Kidd, V. J. (1995). Cell cycle-related protein kinases and T cell death. Adv. Exp. Med. Biol. 376, 247-258.
158. Langlands, K., Yin, X., Anand, G., and Prochownik, E. V. (1997). Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. J. Biol. Chem. 272,19785-19793.
159. Lazaro, J. B., Kitzmann, M., Poul, M. A., Vandromme, M., Lamb, N. J., and Fernandez, A. (1997). Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J. Cell Sei. 110,1251-1260.
160. Lee, Y. Y., Kim, E. S., Seol, J. G., Kim, B. K., Binderup, L., Elstner, E., Park, D. J., and Koeffler, H. P. (1996). Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts. Leukemia 10, 1751-1757.
161. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
162. Li, W. W., Fan, J., Hochhauser, D., and Bertino, J. R. (1997a). Overexpression of p21wafl leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells. Cancer Res. 57, 2193-2199.
163. Li, Z. R., Hromchak, R., and Bloch, A. (1997b). Differential expression of proteins regulating cell cycle progression in growth vs. differentiation. Biochim. Biophys. Ada 1356,149-150.
164. Lim, D. A., Grossen, M., Lehman, C. W., and Botchan, M. R. (1998). Competition for DNA binding sites between the short and long forms of E2 dimers umderlies repression in bovine papillomavirus type 1 DNA replication control. J. Virol. 72, 1931-1940.
165. Liu, M., lavarone, A., and Freedman, L. P. (1996a). Transcriptional activation of the human p21(WAFl/CIPl) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271, 31723-31728.
166. Liu, M., Lee, M. H., Cohen, M., Bommakanti, M., and Freedman, L. P. (1996b). Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10, 142-153.
167. Liu, S. M., Koszewski, N., Lupex, M., Malluche, H. H., Olivera, A., and Russel, J. (1996c). Characterization of a response element in the 5' flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D receptor. Mol. Endocrinol. 10, 206-215.
168. Lois, A. F., Cooper, L. T., Geng, Y., Nobori, T., and Carson, D. (1995). Expression of the p!6 and p!5 cyclin-dependent kinase inhibitors in lymphocytic activation and neuronal differentiation. Cancer Res. 55, 4010-4013.
169. Lomo, J., Smeland, E., Ulven, S., Natarajan, V., Blomhoff, R., Gandhi, U., Dawson, M., and Blomhoff, H. (1998). RAR, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J. Cell. Pliysiol. 175, 68-77.
170. Lowe, W., Meyer, T., Karpen, C., and Lorentzen, L. (1992). Regulation of insulin-like growth factor I production in rat C6 glioma cells: Possible roles as an autocrine/paracrine growth factor. Endocrinology 130, 2683-2691.
171. Lymboussaki, A., Kaipainen, A., Hatva, E., Vastrik, L, Jeskanen, M., Werner, S., Stenback, F., and Alitalo, R. (1996). Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. Br. J. Cancer 73,1347-1355.
172. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Loralin, S., Le Villain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998). Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601-605.
173. Marcinkowska, E., Wiedlocha, A., and Radzikowski, C. (1997). 1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL60 cells. Biochem. Biopliys. Res. Commun. 241, 419-426.
174. Marks, P., Sheffery, M., and Rifkin, R. (1987). Induction of transformed cells to terminal differentiation and the modulation of gene expression. Cancer Res. 47, 659-666.
175. Martinelli, R., Blandino, G., Scardigli, R., Crescenzi, M., Lombardi, D., Sacchi, A., and Soddu, S. (1997). Oncogenes belonging to the CSF-1 transduction pathway direct p53 tumor suppressor effects to monocytic differentiation in 32D cells. Oncogene 15, 607-611.
176. Masui, Y., and Markert, C. L. (1971). Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J. Exp. Zool. 177,129-146.
177. Matsumura, I., Ishikawa, J., Nakajima, K., Oritani, K., Tomiyama, Y., Miyagawa, J., Kato, T., Miyazaki, H., Matsuzawa, Y., and Kanakura, Y. (1997). Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAFl/Cipl) by STATS. Mol. Cell. Biol. 17, 2933-2943.
178. McCabe, L. B., Last, T. J., Lynch, M., Lian, J., Stein, J., and Stein, G. (1994). Expression of cell growth and bone phenotypic gene during the cell cycle of normal diploid osteoblasts and osteosarcoma cells. J. Cell Biochem. 56, 274-282.
179. McCarthy, J. T., Barham, S. S., and Kumar, R. (1984). 1,25-Dihydroxyvitamin D3 rapidly alters the morphology of the duodenal mucosa of rachitic chicks: Evidence for novel effects of 1,25-dihydroxyvitamin D3. J. Steroid Biochem. 21, 253-258.
180. McConnell, B. B., Starborg, M., Brookes, S., and Peters, G. (1998). Inhibitors of cyclindependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Cnrr. Biol. 8, 351-354.
181. McDonald, T. P., and Jackson, C. W. (1994). Mode of inheritance of the higher degree of megakaryocyte polyploidization in C3H mice. I. Evidence for a role of genomic imprinting in megakaryocyte polyploidy determination. Blood 83, 1493-1498.
182. Melloni, E., Pontremoli, S., Michetto, M., Sacco, O., Cakiroglu, A., Jackson, J., Rifkin, R., and Marks, P. (1987). Protein kinase C activity and hexamethylacetamide-induced erythroleukemia cell differentiation. Proc. Natl. Acad. Sei. USA 84, 5282-5286.
183. Minoo, P., Sullivan, W., Solomon, L., Martin, T., Toft, D., and Scott, R. (1989). Loss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of hnRNP proteins. J. Cell Biol. 109, 1937-1946.
184. Missero, C., Di Cunto, F., Kiyokawa, H., Koff, A., and Dotto, G. P. (1996). The absence of p21Cipl/WAFl alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10, 3065-3075.
185. Momoi, T., Kawai, Y., Momoi, M., and Etoh, Y. (1992). Activin synergistically increased c jun mRNA in P19 embryonal carcinoma cells in the presence of retinoic acid. Biochem. Biophys. Res. Commun. 184, 1350-1356.
186. Morgan, D. (1995). Principles of CDK regulation. Nature 374, 131-134.
187. Morioka, K., Tone, S., Mukaida, M., and Takano-Ohmuro, H. (1998). The apoptotic and nonapoptotic nature of the terminal differentiation of erythroid cells. Exp. Cell Res. 240, 206-217.
188. Morse, L., Chen, D., Franklin, D., Xiong, Y., and Chen-Kiang, S. (1997). Induction of cell cycle arrest and B cell terminal differentation by CDK inhibitor p18(INK4c) and IL-6. Immunity 6, 47-56.
189. Mumberg, D., Wick, M., Burger, C, Haas, K., Funk, M., and Muller, R. (1997). Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiation. Nucleic Acids Res. 25, 2098-2105.
190. Murale, T., Saga, S., Hotta, T., Asano, H., Ito, T., Kalo, K., Tsushita, K., Kinoshita, T., Ichikawa, A., and Yoshida, S. (1993). The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages. Exp. Cell Res. 208, 35-43.
191. Nakamura, K., Takahashi, T., Sasaki, Y., Tsuyuoka, R., Okuno, Y., Kurino, M., Ohmoir, K., Iho, S., and Nakao, K. (1996). 1,25-Dihydroxyvitamin D3 differentiates normal neutrophilic promyeloctes to monocytes/macrophages in vitro. Blood 87, 2693-2701.
192. Nakamura, T., Okuyama, S., Okamoto, S., Nakajima, T., Sekiya, S., and Oda, K. (1995). Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site. Exp. Cell Res. 216, 422-430.
193. Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., and Ewen, M. E. (1997). Cyclin Dl stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17,5338-5347.
194. Niculescu, A. B., Chen, X., Smeets, M., Hengst, L., Prives, C, and Reed, S. I. (1998). Effects of p21 (Cipl/Wafl) at both the Gl/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell. Biol. 18, 629-643.
195. Nikolic, M., Dudek, H., Kwon, Y. T., Ramos, Y. F., and Tsai, L. H. (1996). The cdk5/ p35 kinase is essential for neurite outgrowth during neuronal differentiation. Gene Dev. 10, 816-825.
196. Niles, R. M., and Loewy, B. P. (1989). Induction of protein kinase C in mouse melanoma cells by retinoic acid. Cancer Res. 49, 4483-4487.
197. Nishiguchi, Y., Hibasami, H., Komada, Y., Sakurai, M., and Nakashima, K. (1993). Human promyelocytic cell line HL60 has the specific binding sites for prolactin and its ornithine decarboxylase, DNA synthesis and cellular proliferation are induced by prolactin. Leukemia Res. 17, 633-637.
198. Norman, A. W., Bouillon, R., and Thomasset, M. (1997). "Vitamin D. Chemistry, Biology and Clinical Application of the Steroid Hormone." Univ. of California Press, Riverside.
199. Novitch, B. G., Mulligan, G. J., Jacks, T., and Lassar, A. B. (1996). Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell. Biol. 135, 441-456.
200. Nurse, P. (1990). Universal control mechanism regulating the onset of M-phase. Nature 344, 503-508.
201. O'Connor, P.M., and Fan, S. (1996). DNA damage checkpoints: Implications for cancer therapy. Prog. Cell Cycle Res. 2,165-173.
202. Ogino, H., and Yasuda, K. (1998). Induction of lens differentiation by activation of a bZIP transcription factor, L-Maf. Science 280, 115-118.
203. Ohkubo, Y., Kishimoto, T., Nakata, T., Yasuda, H., and Endo, T. (1994). S V40 large T antigen reinduces the cell cycle in terminally differentiated myotubes through inducing Cdk2, Cdc2, and their partner cyclins. Exp. Cell Res. 214, 270-278.
204. Okuyama, Y., Sowa, Y., Fujita, T., Mizuno, T., Nomura, H., Nikaido, T., Endo, T., and Sakai, T. (1996). ATF site of human RB gene promoter is a responsive element of myogenic differentiation. FEBS Lett. 397, 219-224.
205. Onishi, H., Kamano, H., Tanaka, T., Okabe, A., and Irino, S. (1990). p75 c-myb expression in leukemia-lymphoma cells correlated with proliferation and differentiation. Leukemia Res. 14, 423-432.
206. Onishi, T., and Hruska, K. (1997). Expression of p27Kipl in osteoblast-like cells during differentiation with parathyroid hormone. Endocrinology 138, 1995-2004.
207. Oswald, F., Dobner, T., and Lipp, M. (1996). The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle. Mol. Cell. Biol. 16,1889-1895.
208. 3. Carcinogenesis 16, 2091-2097.
209. Owen, T. A., Aronow, M., Shalhoub, V., Barone, L. M., Wilming, L., Tassinari, M. S., Kennedy, M. B., Pockwinse, S., Lian, J. B., and Stein, G. S. (1990). Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143, 420-430.
210. Pan, P., Reddy, K., Lee, S., and Studzinski, G. (1991). Differentiation-related regulation of 1,25-dihydroxyvitamin Dj receptor mRNA in human leukemia cells HL60. Cell Prolif. 24, 159-170.
211. Pardee, A. (1989). Gl events and regulation of cell proliferation. Science 246, 603-608.
212. Parker, L., Sylvestre, P., Byrnes, M., Liu, F., and Piwnica-Worms, H. (1995). Identification of a 95-kDa WEE-1-like tyrosine kinase in HeLa cells. Proc. Natl. Acad. Sei. USA 92,9638-9642.
213. Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W., and Elledge, S. J. (1995). p53-independent expression of p21 Cipl in muscle and other terminally differentiating cells. Science 267,1024-1027.
214. Perez-Roger, I., Solomom, D. L., Sewing, A., and Land, H. (1997). Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27 (Kipl) binding to newly formed complexes. Oncogene 14, 2373-2381.
215. Phelps, D. E., Hsiao, K. M., Li, Y., Hu, N., Franklin, D. S., Westphal, E., Lee, E. Y., and Xiong, Y. (1998). Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol. Cell. Biol. 18, 2334-2343.
216. Piette, J. (1997). The transition from proliferation to differentiation in nerve cells: What can we learn from muscle? Exp. Cell Res. 234, 193-204.
217. Poluha, W., Schonhoff, C. M., Harrington, K. S., Lachyankar, M. B., Crosbie, N. E., Bulseco, D. A., and Ross, A. H. (1997). A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAFl regulates neuronal differentiation of PC12 cells. J. Biol. Chem. 272, 24002-24007.
218. Polyak, K., Kato, J., Solomon, M., Sherr, C., Massague, J., Roberts, J., and Koff, A. (1994). p27/ Kipl, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
219. Pomerantz, J., Schriber-Agus, N., Liegeois, N. J., Silverman, A., Alland, L., Chin, L., Poles, J., Chen, K., Orlow, L, Lee, H. W., Gordon-Cardo, C, and DePinho, R. A. (1998). The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723.
220. Ponten, F., Berne, B., Ren, Z. P., Nister, M., and Ponten, J. (1995). Ultraviolet light induces expression of p53 and p21 in human skin: Effect of sunscreen and constitutive p21 expression in skin appendages. J. Invest. Dermatol. 105, 402-406.
221. Puri, P. L., Avantaggiati, M. L., Balsano, C., Sang, N., Graessmann, A., Giordano, A., and Levrero, M. (1997a). p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16, 369-383.
222. Puri, P. L., Balsano, C., Burgio, V. L., Chirillo, P., Natoli, G., Ricci, L., Mattei, E., Graessmann, A., and Levrero, M. (1997b). MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes. Oncogens 14, 1171-1184.
223. Puri, P. L., Medaglia, S., Cimino, L., Maselli, C., Germani, A., DeMarzio, E., Levrero, M., and Balsano, C. (1997c). Uncoupling of p21 induction and MyoD activation results in the failure of irreversible cell cycle arrest in doxorubicin-treated myocytes. J. Cell. Biochem. 66, 27-36.
224. Puri, P. L., Cimino, L., Fulco, M., Zimmerman, C., LaThangue, N. B., Giordano, A., Graess-mann, A., and Levrero, M. (1998). Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. Cancer Res. 58, 1325-1331.
225. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. (1995). Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000.
226. Queva, C, Hurlin, P. J., Foley, K. P., and Eisenman, R. N. (1998). Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogens 16, 967-977.
227. Rao, J., Zhang, F., Donnelly, R. J., Spector, N. L., and Studzinski, G. P. (1998). Truncation of Spl transcription factor by myeloblastin in undifferentiated HL60 cells. J. Cell. Physiol. 175, 121-128.
228. Reichrath, J., Mittman, M., Kamradt, J., and Muller, S. (1997). Expression of retinoid-X receptors (-alpha, -beta, -gamma) and retinoic acid receptors (-alpha, -beta, -gamma) in normal human skin: An immunohistochemical evaluation. Histochem. J. 29,127-133.
229. Reitsma, P. H., Rothberg, P. G., Astrin, S. M., Trial, J., Bar-Shavit, Z., Hall, A., Teitelbaum, S. L., and Kahn, A. J. (1983). Regulation of myc gene expression in HL-60 leukemia cells by a vitamin D metabolite. Nature 306, 492-494.
230. Rephaeli, A., Rabizadeh, E., Aviram, A., Shaklai, M., Ruse, M., and Nudelman, A. (1991). Derivatives of butyric acid as potential antineoplastic agents. Int. J. Cancer 49, 66-72.
231. Richon, V., Ramsay, R., Rifkin, R., and Marks, P. (1989). Modulation of the c myb, c myc and p53 mRNA and protein levels during induced murine leukemia cell differentiation. Oncogene 4, 165-173.
232. Rickert, P., Seghezzi, W., Shanahan, F., Cho, H., and Lees, E. (1996). Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene 12, 2631-2640.
233. Rifkind, R. A., Richon, V. M., and Marks, P. A. (1996). Induced differentiation, the cell cycle, and the treatment of cancer. Pharmacol. Ther. 2, 97-102.
234. Roodman, G. D. (1996). Advances in bone biology: The osteoclast. Endocr. Rev. 17,308-332.
235. Rots, N. Y., Liu, M., Anderson, E. C, and Freedman, L. P. (1998). A differential screen for ligand-regulated genes: Identification of HoxAlO as a target of vitamin D3 induction in myeloid leukemic cells. Mol. Cell. Biol. 18, 1911-1918.
236. Roussel, M. F., Davis, J. N., Cleveland, J. L., Ghysdael, J., and Hiebert, S. W. (1994). Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 9, 405-415.
237. Roussel, M. F., Ashmun, R. A., Sherr, C. J., Eisenman, R. N., and Ayer, D. E. (1996). Inhibition of cell proliferation by the Madl transcriptional represser. Mol. Cell. Biol. 16, 2796-2801.
238. Roy, R., Adamczewski, J. P., Seroz, T., Vermeulen, W., Tassan, J. P., Schaeffer, L., Nigg, E. A., Hoeijmaker, J. H., and Egly, J. M. (1994). The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79, 1093-1101.
239. Ruis, C., Cabanas, C., and Aller, P. (1990). The induction of vimentin gene expression by sodium butyrate in human promonocytic leukemia U937 cells. Exp. Cell Res. 188,129-134.
240. Ryan, K. M., and Birnie, G. D. (1997a). Cell-cycle progression is not essential for c-myc to block differentiation. Oncogene 14, 2835-2843.
241. Ryan, K. M., and Birnie, G. D. (1997b). Analysis of E-box DNA binding during myeloid differentiation reveals complexes that contain Mad but not Max. Biochem. J. 325, 79-85.
242. Sadhu, K., Reed, S., Richardson, H., and Russell, P. (1990). Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc. Natl. Acad. Sei. USA 87, 5139-5143.
243. Saha, P., Eichbaum, Q., Silberman, E. D., Mayer, B. J., and Dutta, A. (1997). p21CIPl and Cdc25A: Competition between an inhibitor and an activator of cyclin-dependent kinases. Mol Cell. Biol. 17, 4338-4345.
244. Saini, K., Steel, G., and Thomas, P. (1990). Induction of carcinoembryonic antigen gene expression in human colorectal carcinoma by sodium butyrate. Biochem. J. 272, 541-544.
245. Samid, D., Shack, S., and Sherman, L. (1992). Phenylacetate: A novel nontoxic inducer of cell differentiation. Cancer Res. 52, 1988-1992.
246. Sano, M., and Kitajima, S. (1998). Activation of mitogen-activated protein kinases is not required for the extension of neuntes from PC12D cells triggered by nerve growth factor. Brain Res. 785, 299-308.
247. Savatier, P., Lapillonne, H., vanGrunsven, L. A., Rudkin, B. B., and Samarut, J. (1996). Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 12, 309-322.
248. Schwaller, J., Pabst, T., Koeffler, H. P., Niklaus, G., Loetscher, P., Fey, M. F., and Tobler, A. (1997). Expression and regulation of Gl cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells. Leukemia 11, 54-63.
249. Sealy, L., and Chalkley, R. (1979). Modification of histones immediately following synthesis. Arch. Biochem. Biophys. 197, 78-82.
250. Selvakumaran, M., Liebermann, D., and Hoffman, B. (1996). The proto-oncogene c-myc blocks myeloid differentiation independently of its target gene ornithine decarboxylase. Blood 88, 1248-1255.
251. Serrano, M., Hannon, G., and Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CKD4. Nature 366, 704-707.
252. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C, Beach, D., and De Pinho, R. A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
253. Shabahang, M., Buras, R., Davoodi, F., Schumaker, L., Nauta, R., and Evans, S. (1993). 1,25 Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res. 53, 3712-3718.
254. Shabahang, M., Buras, R., Davoodi, F., Schumaker, L., Nauta, R., Uskokovic, M., Brenner, R., and Evans, S. (1994). Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25 dihydroxyvitamin D3. Cancer Res. 54, 4057-4064.
255. Shanmugam, M., Krett, N., Peters, C., Maizels, E., Murad, F., Kawakatsu, H., Rosen, S., and Hunzicker-Dunn, M. (1998). Association of PKC delta and active Src in PMA-treated MCF-7 human breast cancer cells. Oncogene 16, 1649-1654.
256. Shao, R. G., Cao, C. X., Shimizu, T., O'Connor, P. M., Kohn, K. W., and Pommier, Y. (1997). Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cells lines, possibly influenced by p53 function. Cancer Res. 57, 4029-2035.
257. Shao, Z. M., Alpaugh, M. L., Fontana, J. A., and Barsky, S. H. (1998). Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by p21WAFl/CIPl induction, G2/M arrest, and apoptosis. J. Cell. Biochem. 69, 44-54.
258. Sherr, C. (1993). Mammalian G, cyclins. Cell 73, 1059-1065.
259. Sherr, C. (1994). Gl phase progression: Cycling on cue. Cell 79, 551-555.
260. Sherr, C. J. (1996). Cancer cells cycles. Science 274, 1672-1677.
261. Shi, L., Nishioka, W. K., Th'ng, J., Bradbury, E. M., Litchfield, D. W., and Greenberg, A. H. (1994). Premature p34cdc2 activation required for apoptosis. Science 263, 1143-1145.
262. Shiyanov, P., Hayes, S., Chen, N., Pestov, D. G., Lau, L. F., and Raychaudhuri, P. (1997). p27Kipl induces an accumulation of the repressor complexes of E2F and inhibits expression of the E2F-regulated genes. Mol. Biol Cell 8, 1815-1827.
263. Simpson, R. U., Todd, H., Begley, D. A., Mitchell, B. S., and Alizadeh, B. N. (1987). Transcriptional regulation of the c-myc protooncogene by 1,25-dihydroxyvitamin D3 in HL60 promyelocytic leukemia cells. J. Biol. Chem. 262, 4104-4108.
264. Skapek, S. X., Rhee, J., Kim, P. S., Novitch, B. G., and Lassar, A. B. (1996). Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol. Cell. Biol. 16, 7043-7053.
265. Smith, E., Frankel, B., MacLachlan, T. K., Giordano, A., Stein, J. L., Lian, J. B., and Stein, G. S. (1997). Post-proliferative cyclin E-associated kinase activity in differentiated osteoblasts: Inhibition by proliferating osteoblasts and osteosarcoma cells. J. Cell. Biochem. 66, 141-152.
266. Smith, E. J., Leone, G., and Nevins, J. R. (1998). Distinct mechanisms control the accumulation of the Rb-related p107 and pl30 proteins during cell growth. Cell Growth Differ. 9,297-303.
267. Soddu, S., Blandino, G., Scardigi, R., Martinelli, R., Rizzo, M. G., Crescenzi, M., and Sacchi, A. (1996). Wild type p53 induces diverse effects in 32D cells expressing different oncogenes. Mol. Cell. Biol. 16, 487-495.
268. Stein, G. S., Lian, J. B., and Owen, T. A. (1990). Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEBJ. 4,3111-3123.
269. Stein, G. S., Stein, J. L., Van Wijnen, A. J., and Lian, J. B. (1996). Transcriptional control of cell cycle progression: The histone gene is a paradigm for the Gl/S phase and proliferation/ differentiation transitions. Cell Biol. Int. 20, 41-49.
270. Steinman, R. A., Huffman, B., Iro, A., Guillouf, C., Liebermann, D. A., and el-Houseini, M. E. (1994). Induction of p21 (WAF-1/CIP1) during differentiation. Oncogens 9, 3389-3396.
271. Sterner, J. M., Murata, Y., Kim, H. G., Kennett, S. B., Templeton, D. J., and Horowitz, J. M. (1995). Detection of a novel cell cycle-regulated kinase activity that associates with the amino terminus of the retinoblastoma protein in G2/M phases. J. Biol. Cliem. 270,9281-9288.
272. Sterner, J. M., Tao, Y., Kennett, S. B., Kim, H. G., and Horowitz, J. M. (1996). The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression. Cell Growth Differ. 7,53-64.
273. Stewart, C. C. (1984). Regulation of mononuclear phagocyte proliferation. In "The Reticuloendothelial System" (S. M. Reichard and J. P. Filkins, Eds.), Vol. 7A, pp. 37-56. Plenum, New York.
274. Strausfeld, U., Fernandez, A., Capony, J., Girad, F., Lautredou, N., Derancourt, J., Labbe, J., and Lamb, N. (1994). Activation of p34cdc2 protein kinase by microinjection of human cdc25c into mammalian cells. J. Biol. Cliem. 269, 5989-6000.
275. Studzinski, G. P., and Brelvi, Z. S. (1987). Changes in proto-oncogene expression associated with reversal of macrophage-like differentiation of HL60 cells. JNCI79, 67-76.
276. Studzinski, G. P., Bhandal, A., and Brelvi, Z. (1985). A system for monocytic differentiation of leukemic cells HL60 by a short exposure to 1,25-dihydroxycholecalciferol. Proc. Soc. Exp. Biol. Med. 179, 288-295.
277. 3-resistant HL60 cells is preceded by reduced growth factor dependence and constitutive up-regulation of Spl and AP-1 transcription factors. Cancer Res. 56, 5513-5521.
278. Sugawara, A., Sanno, N., Takahashi, N., Osamura, R., and Abe, K. (1997). Retinoid X receptors in the kidney: Their protein expression and functional significance. Endocrinology 138, 3175-3180.
279. Takeda, T., Nishiguchi, S., Kuroki, T., Kobayashi, K., Hasuma, T., Matsui-Yuasa, I., and Otani, S. (1991). Reduction by interferon-alpha of levels of c-myc protein and DNA synthesis in a human hepatoma cell line mediated by inhibition of putrescine synthesis. Biochem. Biophys. Res. Commun. 178, 378-384.
280. Tanaka, E. M., Gann, A. A., Gates, P. B., and Brockes, J. P. (1997). New myotubes reenter the cell cycle by phosphorylation of the retinoblastoma protein. J. Cell Biol. 136,155-165.
281. Tang, X. M., Strocchi, P., and Cambi, F. (1998). Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes. J. Cell. Biochem. 68,128-137.
282. Taylor, C., Kim, Y., Childress-Fields, K., and Yeoman, L. (1992). Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon cancer cell lines. Cancer Lett. 62, 95-105.
283. Tchou, W. W., Rom, W. N., and Tchou-Wong, K. M. (1996). Novel form of p21(\VAFl/CIPl/ SDI1) protein in phorbol ester-induced G2/M arrest. J. Biol. Chem. 271, 29556-29560.
284. Tedesco, D., Caruso, M., Fischer-Fantuzzi, L., and Vesco, C. (1995). The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants. J. Virol. 69, 6947-6957.
285. Thomas, M., Tebbutt, S., and Williamson, R. (1992). Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 33,1660-1663.
286. Thomas, R. C., Edwards, M. J., and Marks, R. (1996). Translocation of the retinoblastoma gene product during mitosis. Exp. Cell Res. 223, 227-232.
287. Thomas, X., Anglaret, B., Thiegaut, A., Belhabri, A., Treille-Ritoouet, D., Fiere, D., and Archimbaud, E. (1997). Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: The role of all-trans retinoic acid therapy. Ann. Hematol. 75, 195-200.
288. Tiainen, M., Pajalunga, D., Ferrantelli, F., Soddu, S., Salvatori, G., Sacchi, A., and Crescenzi, M. (1996a). Terminally differentiated skeletal myotubes are not confined to GO but can enter Gl upon growth factor stimulation. Cell Growth Differ. 7,1039-1050.
289. Tiainen, M., Spitkovsky, D., Jansen, D. P., Sacchi, A., and Crescenzi, M. (1996b). Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms. Mol. Cell. Biol. 16, 5302-5312.
290. Tikoo, R., Casaccia, B. P., Chao, M. V., and Koff, A. (1997). Changes in cyclin-dependent kinase 2 and p27Kipl accompany glial cell differentiation of central glia-4 cells. J. Biol. Chem. 272, 442-447.
291. Urashima, M., DeCaprio, J. A., Chauhan, D., Teoh, G., Ogata, A., Treon, S. P., Hoshi, Y., and Anderson, K. C. (1997). p!6INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells. Blood 90, 4106-4115.
292. Uren, A., Jakus, J., deMora, J. F., Yeudall, A., Santos, E., Gutkind, S., and Heidaran, M. A. (1997). Carboxyl-terminal domain of p27Kipl activates Cdc2. J. Biol. Chem. 272, 21669-21672.
293. Uskokovic, M. R., Studzinski, G. P., Gardner, J. P., Reddy, S. G., Campbell, M. J., and Koeffler, P. H. (1997). The 16-ene vitamin D analogs. Curr. Pharmacol. Design 3, 99-123.
294. Van den Bernd, G., Pols, H., Birkenhager, J., Kleinkoort, W., and van Leeuwen, J. (1995). Differential effects of 1,25 dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption. J. Steroid Biochem. Mol. Biol. 55, 337-346.
295. Van Grunsven, L. A., Billion, N., Savatier, P., Thomas, A., Urdiales, J. L., and Rudkin, B. B. (1996). Effect of nerve growth factor on the expression of cell cycle regulatory proteins in PC12 cells: Dissection of the neurotrophic response from the anti-mitogenic response. Oncogene 12,1347-1356.
296. Van Hal, P. Th., Wijkhuijs, J. M., Mulder, P. G. H., and Hoogseden, H. C. (1995). Proliferation of mature and immature subpopulations of bronchoalveolar monocytes/macrophages and peripheral blood monocytes. Cell Prolif. 28, 533-543.
297. Van Wijnen, A. J., vanGurp, M. F., deRidder, M. C., Tufarelli, C, Last, T. J., Birnbaum, M., Vaughan, P. S., Giordano, A., Krek, W., Neufeld, E. J., Stein, J. L., and Stein, G. S. (1996). CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: A mechanism for gene regulation at the Gl/S phase cell cycle transition point independent of transcription factor E2F. Proc. Natl. Acad. Sei. USA 93, 11516-11521.
298. Vincent, I., Jicha, G., Rosado, M., and Dickson, D. W. (1997). Aberrant expression of mitotic cdc2/cyclin Bl kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17, 3588-3598.
299. Vogt, M., Haggblom, C., Yeargin, J., Christiansen-Weber, T., and Haas, M. (1998). Independent induction of senescence by p16INK4a and p21CIPl in spontaneously immortalized human fibroblasts. Cell Growth Differ. 9,139-146.
300. Waga, S., Hannon, G., Beach, D., and Stillman, B. (1994). The p21 cyclin dependent kinase inhibitor directly controls DNA replication via interaction with PCNA. Nature 369,574-578.
301. Waldman, T., Lenguer, C, Kinzler, K. W., and Volgelstein, B. (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-716.
302. Wali, R., Bissonette, M., Khare, S., Hart, J., Sitrin, M., and Brasitus, T. (1995). 1α, 25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a noncalcemic analogue of 1α,25 dihydroxyvitamin D3, inhibits azoxymethane-induced colonie tumorigenesis. Cancer Res. 55, 3050-3054.
303. Wang, J., and Nadal-Ginard, B. (1995). Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocytes. Biochem. Biophys. Res. Commun. 206,82-88.
304. Wang, J., Guo, K., Willis, K. N., and Walsh, K. (1997). Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res. 57, 351-354.
305. 3 in HL60 cells. Cancer Res. 56, 264-267.
306. Wang, Q. M., Luo, X., and Studzinski, G. P. (1997). Cyclin-dependent kinase 6 is the principal target of p27/kipl regulation of the Gl-phase trasverse in 1,25-dihydroxyvitamin DS-treated HL60 cells. Cancer Res. 57, 2851-2855.
307. Wang, Q. M., Chen, F., Luo, X., Moore, D. C., Flanagan, M., and Studzinski, G. P. (1998). Lowering of p27Kipl levels by its antisense or by development of resistance to 1,25-dihydroxyvitamin D3 reverses the Gl block but not differentiation of HL60 cells. Leukemia, in press.
308. Wang, X., and Studzinski, G. P. (1997). Antiapoptotic action in 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp. Cell Res. 235, 210-217.
309. Wang, X., Gardner, J. P., Kheir, A., Uskokovic, M. R., and Studzinski, G. P. (1997). Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D.JNCI89, 1199-1206.
310. Weima, S., Van Rooigen, M., Feijen, A., Mummery, C, Van Zoelen, E., Delaat, S., and Van Den Eijnden-Van raaij, A. (1989). Transforming growth factor-beta and its receptor are differentially regulated in human embryonal carcinoma cells. Differentiation 41, 245-253.
311. Wisdom, R., and Lee, W. (1990). Translation of c-myc mRNA is required for its post-transcriptional regulation during myogenesis. J. Biol. Client. 265, 19105-19021.
312. Witt, O., Albig, W., and Doenecke, D. (1997). Transcriptional regulation of the human replacement histone gene H3.3B. FEBS Lett. 408, 255-260.
313. Yam, L. T., Li, C. Y., and Crosby, W. (1971). Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Patliol. 55, 283-290.
314. Yan, G. Z., and Ziff, E. B. (1995). NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin Dl. J. Neurosci. 15,6200-6212.
315. Yan, G. Z., and Ziff, E. B. (1997). Nerve growth factor induces transcription of the p21WAFl/ CIP1 and cyclin Dl genes in PC12 cells by activating the Spl transcription factor. J. Neurosci. 17, 6122-6132.
316. Yan, Y., Prisen, J., Lee, M. H., Massague, J., and Barbacid, M. (1997). Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11, 973-983.
317. Yan, Z., DeGregori, J., Shohet, R., Leone, G., Stillman, B., Kevins, J. R., and Williams, R. S. (1998). Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc. Natl. Acad. Sei. USA 95, 3603-3608.
318. Yen, A., and Varvayanis, S. (1994). Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation. Exp. Cell Res. 214, 250-257.
319. Yokoe, H., Masumi-Fukazawa, F. A., Sunohara, M., Tanzawa, H., Sato, K., Sato, T., and Fuse, A. (1997). Induction of polyploidization in the human erythroleukemia cell line (HEL) by protein kinase inhibitor (K252a) and the phorbol-ester TPA. Leukemia Lymphoma 25, 333-343.
320. Yun, K., and Wold, B. (1996). Skeletal muscle determination and differentiation: Story of a core regulatory network and its context. Curr. Opin.
321. Zabludoff, S. D., Csete, M., Wagner, R., Yu, X., and Wold, B. J. (1998). p27Kipl is expressed transiently in developing myotomes and enhances myogenesis. Cell Growth Differ. 9,1-11.
322. Zacksenhaus, E., Jiang, Z., Chung, D., Marth, J. D., Phillips, R. A., and Gallie, B. L. (1996). pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 23, 3051-3064.
323. Zavitz, K. H., and Zipursky, S. L. (1997). Controlling cell proliferation in differentiating tissues: Genetic analysis of negative regulators of Gl →S phase progression. Curr. Opin. Cell Biol. 9, 773-781.
324. Zelent, A., Krust, A., Petrovich, M., Kastner, P., and Chambon, P. (1989). Cloning of murine alpha and beta retinoic receptors and a novel receptor gamma predominantly expressed in the skin. Nature 339, 714-717.
325. Zhang, F., Godyn, J. J., Uskokovic, M., Binderup, L., and Studzinski, G. P. (1994). Monocytic differentiation of HL60 cells induced by potent analogs of vitamin D3 precedes the Gl/GO phase cell cycle block. Cell Prolif. 27, 643-654.
326. Zhang, F., Rathod, B., Jones, J. B., Wang, Q. M., Bernhard, E., Godyn, J. J., and Studzinski, G. P. (1996). Increased stringency of the 1,25-dihydroxyvitamin Dj-induced Gl to S phase block in polyploid HL60 cells. J. Cell Physiol. 168, 18-25.
327. Zhang, Q., Ahuja, H. S., Zakeri, Z. F., and Wolgemuth, D. J. (1997). Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling. Dev. Biol. 183, 222-233.
328. Zhang, W., Grasso, L., McClain, A. M., Cha, Y., Travail, S., Deisseroth, A. B., and Mercer, W. E. (1995). p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompaning monocyte/macrophage differentiation. Cancer Res. 55, 668-674.
329. Zhang, Y., and Chellapan, S. (1996). Transcriptional activation and expression of DP-transcription factors during cell cycle and TPA-induced U937 differentiation. Mol. Cell. Differ. 4, 297-316.
330. Zhang, Y., Xiong, Y., and Yarbarough, W. G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.
331. Zheng, Z., Polakowaka, R., Johnson, A., and Goldsmith, L. (1992). Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth Differ. 3, 225-232.
332. Zukerberg, L. R., Benedict, W. F., Arnold, A., Syson, N., Harlow, E., and Harris, N. L. (1996). Expression of the retinoblastoma protein in low-grade B-cell lymphoma: Relationship to cyclin Dl. Blood 88, 268-276.
333. Zwijsen, R. M., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., and Michalides, R. J. (1997). CDK-independent activation of estrogen receptor by cyclin Dl. Cell 88,405-417.